The FDA announced the first nine companies to be part of its National Priority Voucher program.
Nine medications are on the initial list of program participants, which aims to promote novel treatments that benefit the health interests of Americans.
The Priority Voucher program is a new initiative at the FDA, first announced in June of this year.
No direct quote available in the given text.
Author's summary: FDA's National Priority Voucher Program promotes novel treatments.